700 patients110,866 observations180 daysLIVE

Patient P-02229

Synthetic patientMETA-24 · Day 118 · 55–64 · M · baseline S20Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
61%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S20

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • GI instability+25
  • Inflammatory activity+19
  • Toxicity+13
  • Nutritional resilience-12

What helped?

No interventions yet.

    LIFE OS recommendation
    GI Support Protocol GI-04
    49%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 72% showed improvement
    • median effect visible after 8 days

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    44 min
    improving · +2.9 vs previous 14 d
    Sleep duration
    Wearable
    5.5 h
    stable · +0.2 vs previous 14 d
    Energy level
    Daily log
    3.7/10
    stable · +0.1 vs previous 14 d
    Steps
    Wearable
    4,834
    improving · +244 vs previous 14 d
    GI burden
    Companion
    42.1/100
    stable · +1.0 vs previous 14 d
    Adherence
    Companion
    92.6 %
    stable · +1.8 vs previous 14 d
    Sleep quality
    Wearable
    24.6/100
    improving · +3.4 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    138 mg/dL
    stable · -2.7 vs previous 14 d
    This trajectory is decaying — what would help, what would not
    Steering view →

    Heading towards failing · 50 from the failing basin, 37 from restoration.

    Would help
    • GI-04 GI Support Protocol
      72% improved among 25 similar · onset 8 d · confidence 51%
    • DT-01 Dosing / Timing Recommendation
      75% improved among 16 similar · onset 5 d · confidence 66%
    • HY-01 Hydration Protocol
      82% improved among 11 similar · onset 4 d · confidence 66%
    • More protein
      GI -3.7 next day on high-intake days · n 18
    Would not help
    • Keep simple carbs low
      GI +3.1 next day on high-intake days · n 17
    • Keep fat low
      GI +2.8 next day on high-intake days · n 22
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -3.7supporter · 95%
    • Simple carbohydrates
      +3.1detractor · 95%
    • Dietary fat load
      +2.8detractor · 95%
    • Histamine load
      +1.5no signal · 52%
    • Ultra-processed food
      +1.4no signal · 48%
    • Alcohol
      -0.7no signal · 19%
    • Insoluble fibre
      -0.6no signal · 16%
    • Caffeine
      0no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Butyrate / short-chain fatty acid production 60
      • MicrobiomeButyrate capacity 40/100
      • MicrobiomeF. prausnitzii depleted
    • Autonomic recovery 20
      • WearableShort sleep window
    • Inflammatory signalling 15
      • WearableHRV 34 ms, trending down
    • Mucosal barrier integrity 10
      • WearableSleep 5.5 h, below personal baseline
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 2.1 · butyrate capacity 40/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisNormal
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    39 ms
    Sleep
    6.4 h
    Steps
    4,836
    Resting HR
    69 bpm
    Daily log: GI score 42, nutritional resilience 53, adherence 93.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
    • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Track each bowel movement today: time, stool form, urgency, overnight waking
    • A 15-minute walk after lunch
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • Electrolyte solution, one sachet after any loose stool
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0235433%S01CR-01improved78
    P-0204832%S0277
    P-0211531%S14GI-04improved75
    P-0244330%S1875
    P-0236531%S0872
    P-0269833%S06ME-01improved71
    P-0255333%S1371
    P-0240335%S0371
    P-0233531%S0470
    P-0255035%S0170
    P-0219234%S0569
    P-0265939%S0969